Citations

Clear

2303 citation(s) found for "Yu, Edward".

Aquablation therapy in large prostates (80–150 cc) for lower urinary tract symptoms due to benign prostatic hyperplasia: WATER II 3‐year trial results
Zorn, Kevin C. , Bidair, Mohamed , Trainer, Andrew, Arther, Andrew, Kramolowsky, Eugene V., Desai, Mihir , Doumanian, Leo, Elterman, Dean , Kaufman, Ronald P., Lingeman, James E., Krambeck, Amy E. , Eure, Gregg , Badlani, Gopal , Plante, Mark , Uchio, Edward , Gin, Greg , Goldenberg, S. Larry , Paterson, Ryan F. , So, Alan , Humphreys, Mitchell R. , Roehrborn, Claus G. , Kaplan, Steven A. , Motola, Jay , Bhojani, Naeem , Humphreys, Mitchell

Mayo Clinic

BJUI Compass | October 29, 2021 | Volume: 3 | Issue: 2 | Pages: 130-138

10.1002/bco2.121 | PMID 35474721 Get It

AbstractObjectiveThe objective of this study is to determine if Aquablation therapy can maintain its effectiveness in treating men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) with large‐volume (80–150 cc) prostates at 3 years.Subjects and MethodsOne hundred one men with moderate‐to‐severe BPH symptoms and prostate volumes between 80 and 150 cc were enrolled in a prospective, nonrandomized, multicenter, international clinical trial in late 2017. Baseline, procedural, and follow‐up parameters were recorded at baseline and scheduled postoperative visits. IPSS, Qmax, and treatment failure are reported at 3 years.ResultsThe mean prostate volume was 107 cc (range 80–150). Mean IPSS improved from 23.2 at baseline to 6.5 at 3 years (16.3‐point improvement, p < 0.0001). Mean IPSS quality of life improved from 4.6 at baseline to 1.1 at 3 years (improvement of 3.4 points, p < 0.0001). Maximum urinary flow increased from 8.7 to 18.5 cc/s. At 3 year follow‐up, 6% of treated patients needed BPH medication and an additional 3% required surgical retreatment for LUTS.ConclusionsThree‐year follow‐up demonstrates a sustained symptom reduction response along with low irreversible complications to Aquablation in men with LUTS due to BPH and prostates of 80–150 cc. Current treatment options available for men with prostates of this size have similar efficacy outcomes but are burdened with high rates of irreversible complications. There are now numerous clinical studies with Aquablation used in various prostates sizes, and it should be offered as an option to men with LUTS due to BPH.
S967 The Correlation Between Visceral Abdominal and Total Adipose Tissue With Metabolic Risk Factors in Patients With Inflammatory Bowel Diseases
Yarur, Andrés , Núñez, Lizbeth, Berens, Brandon, Moosreiner, Andrea , Sekhri, Shaina , Beniwal‐Patel, Poonam , Bruss, Alexandra, Yarur, Andres J , Wiesner, Matthew, Deepak, Parakkal , Loftus, Edward V.

Mayo Clinic

American Journal of Gastroenterology | October 24, 2021 | Volume: 116 | Issue: 1 | Pages: S463-S463

10.14309/01.ajg.0000777400.37055.33 Get It

S930 Safety of Ustekinumab Across Approved Adult Indications: Pooled Safety Analysis in Crohn’s Disease, Ulcerative Colitis, Psoriasis, and Psoriatic Arthritis Through up to 5 Years
Long, Millie D. , Ott, Elyssa , Gasink, Christopher , Ye, Miao , Baker, Thomas, Tikhonov, Ilia , Rahman, Proton , Danese, Silvio , Strober, Bruce E , Loftus, Edward V.

Mayo Clinic

American Journal of Gastroenterology | October 24, 2021 | Volume: 116 | Issue: 1 | Pages: S441-S441

10.14309/01.ajg.0000777252.35443.aa Get It

S923 Clostridium difficile Infection in Patients Treated With Tofacitinib in the Ulcerative Colitis Clinical Program
Baumgart, Daniel C. , Connelly, Susan B. , Su, Chinyu , Kinnucan, Jami , Loftus, Edward V. , Armuzzi, Alessandro , Gecse, Krisztina Barbara , Kwok, Kenneth , Guo, Xiang

Mayo Clinic

American Journal of Gastroenterology | October 24, 2021 | Volume: 116 | Issue: 1 | Pages: S437-S437

10.14309/01.ajg.0000777224.78256.d2 Get It

S854 Upadacitinib Is Effective at Inducing Clinical Remission and Response in Ulcerative Colitis Patients Regardless of Baseline Corticosteroid Use: Results From Two Phase 3 Studies
Finney‐Hayward, Tricia , Ilo, Dapo, Phillips, Charles M., Yao, Xuan , Rubin, David T. , Raine, Tim , Loftus, Edward V. , Targownik, Laura E. , Vermeire, Séverine , Danese, Silvio

Mayo Clinic

American Journal of Gastroenterology | October 24, 2021 | Volume: 116 | Issue: 1 | Pages: S398-S398

10.14309/01.ajg.0000776948.02517.78 Get It

S851 Health-Related Quality of Life With Ustekinumab vs Adalimumab for Induction and Maintenance Therapy in Biologic-Naïve Patients With Moderate-To-Severe Crohn’s Disease: PROMIS-29 in the SEAVUE Study
Lewis, James D. , Irving, Peter M., Hoops, Timothy, Izanec, James L., Ding, Zhijie , Muser, Erik, Gasink, Christopher , Lewis, James D , Allez, Matthieu , Ma, Tony Xuyen , Panaccione, Remo , Loftus, Edward V. , Danese, Silvio , Sands, Bruce E

Mayo Clinic

American Journal of Gastroenterology | October 24, 2021 | Volume: 116 | Issue: 1 | Pages: S395-S395

10.14309/01.ajg.0000776936.46186.11 Get It

S778 A Cross-Sectional Evaluation of the Prevalence of Pulmonary Diseases in Patients With Inflammatory Bowel Disease
Pemmasani, Gayatri , Tremaine, William J., Loftus, Edward V.

Mayo Clinic

American Journal of Gastroenterology | October 24, 2021 | Volume: 116 | Issue: 1 | Pages: S360-S361

10.14309/01.ajg.0000776644.58292.96 Get It

S773 Rapidity of Symptom Control with Upadacitinib Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Results From Two Randomized Phase 3 Studies
Takeuchi, Ken , Gao, Xiang , Ilo, Dapo, Finney‐Hayward, Tricia , Phillips, Charles M., Yao, Xuan , Loftus, Edward V. , Panaccione, Remo , Danese, Silvio , Vermeire, Séverine

Mayo Clinic

American Journal of Gastroenterology | October 24, 2021 | Volume: 116 | Issue: 1 | Pages: S359-S359

10.14309/01.ajg.0000776624.73243.66 Get It

S772 Risankizumab Therapy Induces Improvements in Endoscopic Endpoints in Patients With Moderate-To-Severe Crohn’s Disease: Results From the Phase 3 ADVANCE and MOTIVATE Studies
Ferrante, Marc , Baert, Filip , Feagan, Brian G. , Ran, Zhihua , D’Haens, Geert , Song, Alexandra , Neimark, Ezequiel, Liao, Xiaomei, Berg, Sofie, Wallace, Kori, Bossuyt, Peter , Danese, Silvio , Loftus, Edward V. , Panés, Julián , Peyrin‐Biroulet, Laurent , Armuzzi, Alessandro , Zhou, Qian , Panaccione, Remo

Mayo Clinic

American Journal of Gastroenterology | October 24, 2021 | Volume: 116 | Issue: 1 | Pages: S357-S358

10.14309/01.ajg.0000776620.39225.48 Get It